Abstract Submission Deadline: July 31, 2022

Judges

ABSTRACT REVIEW COMMITTEE

Paul Boutros, PhD, MBA

Director of Cancer Data Science, Jonsson Comprehensive Cancer Center; Associate Director of Cancer Informatics at the Institute for Precision Health; and Professor of Urology and Human Genetics, UCLA

Sigrid Carlsson, MD, PhD, MPH

Assistant Attending Epidemiologist, Departments of Surgery (Urology Service) and Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center and Associate Professor of Experimental Urology, Sahlgrenska Academy, Gothenburg University, Sweden

 

Ethan Halpern, MD

Professor and Vice Chair for Research; Co-Director, Prostate Diagnostic Center; and Director, Cardiac CT, Thomas Jefferson University

Jim C. Hu, MD, MPH

Ronald P. Lynch Professor of Urologic Oncology and Professor of Urology, Weill Cornell Medical College, Cornell University; and Attending Urologist, New York-Presbyterian Hospital

 

Andrei H. Iagaru, MD, FACNM

Bio

Andrei Iagaru, MD, FACNM

Professor of Radiology – Nuclear Medicine Chief, Division of Nuclear Medicine and Molecular Imaging Co-Director, PET-MRI Research Program Stanford University

 

Sanoj Punnen, MD, MAS

Co-Chair of Genitourinary Site Disease Group, Pap Corps Champions for Cancer Research Endowed Chair in Solid Tumor Research and
Associate Professor, Department of Urology, University of Miami, Miller School of Medicine

 

Andrei Purysko, MD

Clinical Associate Professor of Radiology, Cleveland Clinic Lerner College of Medicine at Case Western Reserve University; Staff, Section of Abdominal Imaging and Nuclear Radiology, Imaging Institute, Cleveland Clinic; Staff, Glickman Urological and Kidney Institute, Cleveland Clinic

 

Grannum Sant, MD, FRCS, FACS

Grannum Sant, MD, FRCS, FACS

Professor and Former Chair of Urology, Tufts University School of Medicine; Former Head, Oncology/Urology Medical Affairs, Sanofi, and Rare Genetic Diseases, Genzyme

 

Daniel Y. Song, MD

Professor of Radiation Oncology and Molecular Radiation Sciences, and Co-Director, Prostate Cancer Multi-Disciplinary Clinic, Johns Hopkins University

 

Clare M. C. Tempany-Afdhal, MB BAO BCh, FACR, FISMRM, Ferenc Jolesz MD

Professor of Radiology Harvard Medical School; Vice-Chair, Radiology Research Brigham & Women’s Hospital; Director of the Ferenc Jolesz National Center for Image-Guided Therapy & AMIGO; and Chair, Joint American College of Radiology, AdMeTech Foundation and European Society of Urogenital Radiology Steering Committee on PI-RADS Standardization

 

Wolfgang Weber, MD

Professor and Chair, Department of Nuclear Medicine, Klinikum der Isar, Technical University of Munich, Germany

Abstract Competition Rules

Deadline:  All Abstracts are due electronically by July 31, 2022.

 

Suggested Guidelines for the Abstract Submission 

Provide information for each section listed below in the body of your abstract:

  • Title
  • Authors and organizational affiliations  (with email for contact author)
  • Introduction and overall goal
  • Specific aims
  • Rationale and background
  • Methods and materials
  • Results
  • Discussion and conclusion
  • References (optional)

References Format

If there are citations, list references numerically at the end of the abstract in the order by which they were cited in the text.

Example: Cooperberg, MR, Broering, JM, Carroll PR, et. al. Time trends and local variation in primary treatment of localized prostate cancer, Journal of Clinical Oncology 2010 (28): 1117-1123.

Length, Font, and Format

The abstract should not exceed one page (single spaced). Use font no smaller than “Times New Roman 12” or “Arial 11”, and margins of at least 0.5 in.

 

General Content and Guidelines

  1. The content may not promote the proprietary interests of any commercial entity. Evident bias in favor of a particular product or company is grounds for rejection.
  2. Content must be restricted to pure science, technology, methodology, materials and/or operational characteristics of devices. Product and company names should be included only to identify the technology or methodology used, but not to promote proprietary interests.
  3. All research must conform to generally accepted standards of experimental design, data collection and analysis.
  4. The submitted abstract does not have to be an original submission and can be an encore abstract (i.e., it can have been submitted elsewhere).

 

Review Criteria

  1. Is this research novel?
  2. Does this research advance knowledge, and/or improve diagnostic information and/or capabilities?
  3. Does it produce new data or analysis of interest and relevance to the research or clinical community?
  4. Is the data substantive and not just implied? Does it describe a research accomplishment, rather than work yet to be done?
  5. Is comprehensive statistical analysis relevant and applied?
  6. Are recommendations involving clinical medicine based on evidence that is accepted as adequate justification for indications and contraindications in patient care?
  7. What is the impact factor of this work? The abstract should address how the proposed study is expected to impact research or patient care.
  8. Is the abstract biased in favor of a particular product or company? Evident bias is grounds for rejection. (Use of a particular company’s products or equipment does not represent bias. Non-data- based statements of comparative superiority, however, would be considered biased.)

 

Abstract Publication, Competition and Presentation

If your abstract is selected, it will be published electronically on the dedicated Summit 2022 website pages of the AdMeTech Foundation and Grand Rounds in Urology, with the combined outreach to over 21,000 genito-urinary experts, leaders of advocacy and legislature.

All abstracts will undergo a peer review, will be scored and take part in a competition. The authors of the top three abstracts will have an opportunity to have presentations of their work (3 minutes each) during the main scientific program on Saturday, September 24, 2022.

 

If your abstract is accepted and wins one of the top three spots, you will be required to provide a 3-minute video of your presentation by August 1, 2022, preferably in a Zoom format, to Emma Couillard by email at emma.couillard@admetechfoundation.org. Prior to its submission, please upload your video into Google Drive and then share it as the editable file with the above listed email address. This way, your video can be downloaded and professionally edited, if needed. If you need any assistance with or questions about preparing your video, please contact Emma Couillard by email as above.

 

Winners of the top three abstracts will be announced on the dedicated AdMeTech Foundation’s website pages, social media and dedicated newsletters. They will also receive free registrations for Summit 2023.

Failure to Present

Submission of an abstract is considered a commitment to present the poster during main scientific program, if it is accepted and wins one of the top three places. Failure to present a poster may jeopardize future submissions by the same author.

Submission

Please send abstract in a PDF format to faina.shtern@admetechfoundation.org with the Subject Line “2022 Summit Abstract” by Sunday, July 31, 2022.